{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:07:10Z","timestamp":1759972030148,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA041978"],"award-info":[{"award-number":["R01DA041978"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["ANRS 12353"],"award-info":[{"award-number":["ANRS 12353"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>HCV incidence among people who inject drugs (PWID) remains unacceptably high. Using the data from the DRIVE study, we aimed to describe HCV incidence trends and investigate its associated risk factors among PWID in Hai\u00a0Phong, Vietnam.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Active PWID were recruited through 3 annual respondent-driven sampling (RDS) surveys; part of them were included in the study cohorts. HCV seroincidence was calculated for PWID participating in multiple surveys (recaptures) or in cohorts. A nested case\u2013control design was used for risk factor analysis. Controls were matched to HCV seroconversion cases on age, sex, cohort participation and HCV seroconversion visit. Risk factors were measured over the period preceding the HCV seroconversion visits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There were 83 HCV seroconversions during 844 person-years in 540 included participants. The overall HCV incidence was 9.8\/100 person-years (95% CI 7.9\u201312.2). HCV incidence decreased over follow-up time and was particularly high among PWID living with HIV (PLWH), i.e., 37.2\/100 person-years (95% CI 26.4\u201352.3). HIV infection (OR\u2009=\u200910.0, 95% CI 6.8\u201316.2) and active heroin injection (OR: 3.2, 95% CI 2.3\u20134.8) were associated with a higher risk of HCV seroconversion for cohort participants. Among RDS recaptures, living with a sexual partner and currently using methadone had opposite effects on HCV incidence, OR\u2009=\u20092.9, 95% CI 2.2\u20134.3 and OR\u2009=\u20090.4, 95% CI 0.3\u20130.5, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>HCV incidence among PWID in Hai\u00a0Phong was still 5 times higher than the WHO target for elimination. Along with strengthened HCV prevention programs, affordable HCV treatment should be made available for PWID to reach the elimination goal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s12072-025-10856-w","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T18:47:10Z","timestamp":1752778030000},"page":"1077-1086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C virus incidence trend and its risk factors among people who inject drugs in Hai Phong, Vietnam"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3881-6545","authenticated-orcid":false,"given":"Hong Thi","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huong Thi","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khue Minh","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binh Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roselyne","family":"Vallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgana","family":"D\u2019Ottavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giang Thi","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinh Hai","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oanh Thi Hai","family":"Khuat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh Tuyet Thi","family":"Nham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duc Quang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Quillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Rapoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Van de Perre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Feelemyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Laureillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don","family":"Des Jarlais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Moles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Nagot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"10856_CR1","unstructured":"World Health Organization. Global hepatitis report 2024. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240091672"},{"issue":"5","key":"10856_CR2","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/S2214-109X(23)00057-8","volume":"11","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S, et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob Health 2023;11(5):e659\u2013e672. https:\/\/doi.org\/10.1016\/S2214-109X(23)00057-8","journal-title":"Lancet Glob Health"},{"key":"10856_CR3","unstructured":"WHO. Interim Guidance for Country Validation of Viral Hepatitis Elimination. Geneva: WHO; 2021. pp. 1\u201396. https:\/\/www.who.int\/publications\/i\/item\/9789240028395"},{"issue":"1","key":"10856_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RM Fernandes","year":"2017","unstructured":"Fernandes RM, Cary M, Duarte G, Jesus G, Alarc\u00e3o J, Torre C, et al. Effectiveness of needle and syringe Programmes in people who inject drugs\u2014an overview of systematic reviews. BMC Public Health 2017;17(1):1\u201315","journal-title":"BMC Public Health"},{"key":"10856_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100468","volume":"24","author":"B Flower","year":"2022","unstructured":"Flower B, Du Hong D, Vu Thi Kim H, Pham Minh K, Geskus RB, Day J, et al. Seroprevalence of hepatitis B, C and D in Vietnam: a systematic review and meta-analysis. Lancet Reg Health 2022;24: 100468. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100468","journal-title":"Lancet Reg Health"},{"issue":"1","key":"10856_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-63990-w","volume":"10","author":"JP Mol\u00e8s","year":"2020","unstructured":"Mol\u00e8s JP, Vallo R, Khue PM, Huong DT, Oanh KTH, Thoa NT, et al. HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam. Sci Rep 2020;10(1):1\u20138","journal-title":"Sci Rep"},{"issue":"1","key":"10856_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2360-6","volume":"17","author":"A Berto","year":"2017","unstructured":"Berto A, Day J, Van Vinh CN, Thwaites GE, My NN, Baker S, et al. Current challenges and possible solutions to improve access to care and treatment for hepatitis C infection in Vietnam: a systematic review. BMC Infect Dis 2017;17(1):1\u201310","journal-title":"BMC Infect Dis"},{"issue":"15","key":"10856_CR8","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1097\/QAD.0000000000002712","volume":"34","author":"DC des Jarlais","year":"2020","unstructured":"des Jarlais DC, Huong DT, Oanh KTH, Feelemyer JP, Arasteh K, Khue PM, et al. Ending an HIV epidemic among persons who inject drugs in a middle-income country: extremely low HIV incidence among persons who inject drugs in Hai Phong, Viet Nam. AIDS 2020;34(15):2305\u20132311","journal-title":"AIDS"},{"key":"10856_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.drugalcdep.2017.11.033","volume":"185","author":"D Des Jarlais","year":"2018","unstructured":"Des Jarlais D, Khue PM, Feelemyer J, Arasteh K, Thi Huong D, Thi Hai Oanh K, et al. Using dual capture\/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. Drug Alcohol Depend 2018;185:106\u2013111","journal-title":"Drug Alcohol Depend"},{"key":"10856_CR10","first-page":"1","volume":"27","author":"HT Duong","year":"2022","unstructured":"Duong HT, Moles JP, Pham KM, Vallo R, Hoang GT, Vu VH, et al. A community-based intervention to decrease the prevalence of HIV viremia among people who inject drugs in Vietnam. Lancet Reg Health West Pac 2022;27:1\u201311","journal-title":"Lancet Reg Health West Pac"},{"issue":"7","key":"10856_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","volume":"31","author":"KA Bradley","year":"2007","unstructured":"Bradley KA, Debenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. Audit-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007;31(7):1208\u20131217","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"10856_CR12","first-page":"552","volume":"34","author":"S Duan","year":"2013","unstructured":"Duan S, Han J, Tang RH, et al. Study on the incidence and risk factors of HCV infection among heroin addicts who were on methadone maintenance treatment in Dehong prefecture, Yunnan province. Zhonghua Liu Xing Bing Xue Za Zhi 2013;34(6):552\u2013556","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"6","key":"10856_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0097726","volume":"9","author":"J Grebely","year":"2014","unstructured":"Grebely J, Lima VD, Marshall BDL, Milloy MJ, DeBeck K, Montaner J, et al. Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996\u20132012. PLoS ONE 2014;9(6):1\u201310","journal-title":"PLoS ONE"},{"issue":"2","key":"10856_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofaa033","volume":"7","author":"H Hoel","year":"2020","unstructured":"Hoel H, Ueland T, Hove-Skovsgaard M, Hartling HJ, Gelpi M, Benfield T, et al. Soluble T-cell immunoglobulin mucin domain-3 is associated with hepatitis C virus coinfection and low-grade inflammation during chronic human immunodeficiency virus infection. Open Forum Infect Dis 2020;7(2):1\u20137","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10856_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11524-017-0207-5","volume":"95","author":"E Spada","year":"2018","unstructured":"Spada E, Rezza G, Garbuglia AR, Lombardo FL, Zuccaro O, Menniti Ippolito F, et al. Incidence and risk factors for hepatitis C virus infection among illicit drug users in Italy. J Urban Health 2018;95(1):99\u2013110","journal-title":"J Urban Health"},{"issue":"8","key":"10856_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/cid\/cir991","volume":"54","author":"RA Weinstein","year":"2012","unstructured":"Weinstein RA, Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis 2012;54(8):1167\u20131178","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10856_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1360-0443.2011.03765.x","volume":"107","author":"ER Pouget","year":"2012","unstructured":"Pouget ER, Hagan H, Des Jarlais DC. Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction 2012;107(6):1057\u20131065","journal-title":"Addiction"},{"issue":"4","key":"10856_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s11524-015-9966-z","volume":"92","author":"HV Tran","year":"2015","unstructured":"Tran HV, Le LVN, Johnston LG, Nadol P, Van Do A, Tran HTT, et al. Sampling males who inject drugs in Haiphong, Vietnam: comparison of time-location and respondent-driven sampling methods. J Urban Health 2015;92(4):744\u2013757","journal-title":"J Urban Health"},{"issue":"1","key":"10856_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21101\/cejph.a3602","volume":"19","author":"TV \u010cavlek","year":"2011","unstructured":"\u010cavlek TV, Mari\u0107 J, Kati\u010di\u0107 L, Kolari\u0107 B. Hepatitis C virus antibody status, sociodemographic characteristics, and risk behaviour among injecting drug users in Croatia. Cent Eur J Public Health 2011;19(1):26\u201329. https:\/\/doi.org\/10.21101\/cejph.a3602","journal-title":"Cent Eur J Public Health"},{"key":"10856_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/jfmpc.jfmpc_1835_20","volume":"10","author":"S Khan","year":"2021","unstructured":"Khan S, Shah S, Ashraf H. Predictive factors for acquiring HCV infection in the population residing in high endemic, resource-limited settings. J Fam Med Prim Care 2021;10:167\u2013174","journal-title":"J Fam Med Prim Care."},{"issue":"12","key":"10856_CR21","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","volume":"174","author":"JI Tsui","year":"2014","unstructured":"Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Opioid agonist therapy is associated with lower incidence of hepatitis C virus infection in young adult persons who inject drugs HHS Public Access. JAMA Intern Med 2014;174(12):1974\u20131981","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10856_CR22","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1111\/add.12682","volume":"109","author":"S Nolan","year":"2014","unstructured":"Nolan S, Dias Lima V, Fairbairn N, Kerr T, Montaner J, Grebely J, et al. The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. Addiction 2014;109(12):2053\u20132059","journal-title":"Addiction"},{"key":"10856_CR23","first-page":"1","volume":"37","author":"N Nagot","year":"2023","unstructured":"Nagot N, Binh NT, Hong TT, Vinh VH, Quillet C, Vallo R, et al. A community-based strategy to eliminate hepatitis C among people who inject drugs in Vietnam. Lancet Reg Health West Pac 2023;37:1\u201310","journal-title":"Lancet Reg Health West Pac"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10856-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10856-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10856-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:49:16Z","timestamp":1759949356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10856-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10856"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10856-w","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"type":"print","value":"1936-0533"},{"type":"electronic","value":"1936-0541"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hong Thi Tran, Huong Thi Duong, Khue Minh Pham, Binh Thanh Nguyen, Roselyne Vallo, Morgana D\u2019Ottavi, Giang Thi Hoang, Vinh Hai Vu, Oanh Thi Hai Khuat, Thanh Tuyet Thi Nham, Duc Quang Nguyen, Catherine Quillet, Delphine Rapoud, Philippe Van de Perre, Jonathan Feelemyer, Laurent Michel, Didier Laureillard, Don Des Jarlais, Jean-Pierre Moles and Nicolas Nagot declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The DRIVE study was approved by the Institutional Review Board (IRB) of New York University and Hai Phong University of Medicine and Pharmacy, Vietnam. This secondary analysis of was approved by the Ethics Committee of the London School of Hygiene and Tropical Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}